As of Oct 06
| 0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for Five Prime Therapeutics Inc have a median target of 33.50, with a high estimate of 45.00 and a low estimate of 30.00. The median estimate represents a +108.98% increase from the last price of 16.03.
The current consensus among 4 polled investment analysts is to Buy stock in Five Prime Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.